Pfizer-BioNTech mRNA COVID-19 vaccine

BIOLOGICAL3 trials

Sponsors

University of Michigan, Henry M. Jackson Foundation for the Advancement of Military Medicine, University of Florida

Conditions

COVID - 19COVID -19COVID 19COVID-19Corona Virus InfectionInfluenzaRespiratory VirusRespiratory Virus Infection

Phase 2

Universal Immunization to Fortify Immunotherapy Efficacy and Response

Not yet recruitingNCT07597070

University of FloridaStage 4 NSCLC

Start: 2026-09-01End: 2035-03-01Target: 500Updated: 2026-06-08

Phase 4

Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction

CompletedNCT05212610

University of MichiganCorona Virus Infection, COVID-19

Start: 2022-03-21End: 2025-03-07Updated: 2026-03-27

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Active, not recruitingNCT07287137

Henry M. Jackson Foundation for the Advancement of Military MedicineCOVID 19, COVID -19, COVID - 19 +5

Start: 2025-11-12End: 2027-09-01Target: 54Updated: 2026-09-11